Bioanalysis and Validation of Fesoterodine, an Antimuscarinic Agent and its Active Metabolite Using Liquid Chromatography with Tandem Mass Spectrometry

ABSTRACT

Aim: To establish a bioanalytical method with rapid, specific and sensitiveness with tandem mass spectrometric with liquid chromatography for an antimuscuranic agent, fesoterodine and its metabolite, 5-hydroxy methyl tolterodine in plasma of human, using their isotopic labeled compounds correspondingly, with internal standards, fesoterodine d14 and 5-hydroxy methyl tolterodine d14. Materials and Methods: The extraction of analytes is by employing tert-butyl methyl ether, divided with Kromasil 100 column C18using the mixture of mobile phase containing methanol and 5 mM ammonium formate buffer (PH 3.5) at a rate of 1 mL/min. The outstanding linearity was shown in the range of concentrations, 0.1022 to 15.0154 and 0.1022 to 15.0211 ng/ mL for fesoterodine and its metabolite simultaneously. The lower limit of quantitation values is 0.1022 and 0.1022 ng/mL respectively for fesoterodine and 5-hydroxy methyl tolterodine. Results: The accuracy and repeatability results for four different batches at five different concentration levels were discovered to be in the limits of acceptability for ICH guidelines. Stability tests, including benchtop, injector, freeze-thaw cycles, and -20ºC storage, confirmed fesoterodine and its metabolite stability in plasma. The chromatographic elution time of 2.5 min enabled the analysis of 300 samples rapidly in a day for the established technique. Validation results qualified the method for regular analysis and pharmacokinetic studies of fesoterodine and 5-hydroxy methyl tolterodine, its metabolite in the human biological fluid, plasma.

KEYWORDS

• 5-hmt
• Antimuscuranic agent
• Fesoterodine
• Freeze thaw cycles
• Human plasma
• LC-MS/MS
• Pharmacokinetic

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20250467Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 59, ISSUE 2SA Qualitative Study on Lecture Capturing System in Pharmacy Education-Learners’ PerspectiveSaranraj Loganathan, Rajkumaran Soundarraj, Vishwalingam Murugan Sujetha · pp. s410–s413Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SFormulation and Evaluation of Simvastatin Loaded Nanostructured Lipid Carrier for Topical Drug DeliveryMadhuri Desai, Shalaka Dhanna, Sujata Jadhav, Akshada Koparde, Akansha Dashwanat, Rutuja Gharal · pp. s414–s425Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SOptimized Vildagliptin Microsphere Formulation and in vitro Characterization Using 23 Factorial Design AnalysisSundaramoorthi Revathi, Pavadai Anitha, Sathappan Jenifer, Sivakumar Senthil Rajan · pp. s426–s435Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SBilosome Nanocarriers for Enhanced Oral Bioavailability and Cardiovascular Activity of MilrinoneKiruthika Santhinathan, Susmitha Durai, Rijivana Sirajudeen, Gopinath Govindhraji, Saravanan Gopal, Gayathri Kumararaja · pp. s436–s442Original ArticleSame type: Article